The drug company is the latest to sue over a provision of the Inflation Reduction Act requiring pharmaceutical companies to negotiate prices with the federal Medicare program.

Amid the global clamor for more vaccine doses, the largest pharmaceutical companies are helping manufacture doses for less-experienced rivals.